These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6464785)

  • 1. On the pharmacokinetics of fenflumizole, a novel antiinflammatory agent, after single oral administration to healthy subjects.
    Midskov C; Vinge E; Andersson KE
    Acta Pharmacol Toxicol (Copenh); 1984 May; 54(5):408-13. PubMed ID: 6464785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 14C-fenflumizole after intravenous administration to man.
    Vinge E; Midskov C; Arnold E
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):355-62. PubMed ID: 3739729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single intravenous and oral doses of fenflumizole: pharmacokinetics and effects on prostanoid formation.
    Vinge E; Arnold E; Rasmussen SN; Midskov C
    Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):121-9. PubMed ID: 3840639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic and ulcerogenic effects of fenflumizole, a new anti-inflammatory imidazole derivative, in rats.
    Nabata H; Uchino M; Okazaki A; Yamazaki T; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):93-6. PubMed ID: 3114525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effects of fenflumizole, a new anti-inflammatory drug, in dogs.
    Nabata H; Uchino M; Okazaki A; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):97-100. PubMed ID: 3626187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ethimizol in man.
    Trnovec T; Soltés L; Durisova M; Kállay Z; Koprda V; Piotrovskii LB
    Pharmazie; 1985 Jun; 40(6):410-1. PubMed ID: 4034651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of piroximone (MDL 19.205) in healthy volunteers.
    Haegele KD; Belz GG; Meinicke TT; Schechter PJ
    Eur J Clin Pharmacol; 1986; 31(2):239-42. PubMed ID: 3803422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversed-phase chromatography of fenflumizole, a new potential anti-inflammatory agent, and its application in pharmacokinetic studies in rat, dog and man.
    Midskov C
    J Chromatogr; 1983 Nov; 278(1):109-15. PubMed ID: 6662868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.
    Vinge E; Corell T; Andersson KE
    Eur J Clin Pharmacol; 1984; 26(6):711-7. PubMed ID: 6436029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of tomoxiprole, a new analgesic antiinflammatory agent, in the rat.
    Assandri A; Bernareggi A; Ripamonti A; Perazzi A; Toja E
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):161-70. PubMed ID: 4043144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.
    Pentikäinen PJ; Neuvonen PJ; Backman C
    Eur J Clin Pharmacol; 1981; 19(5):359-65. PubMed ID: 7238564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics and dose proportionality of oral cibenzoline.
    Khoo KC; Szuna AJ; Colburn WA; Aogaichi K; Morganroth J; Brazzell RK
    J Clin Pharmacol; 1984 Jul; 24(7):283-8. PubMed ID: 6480874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of indomethacin.
    Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L
    Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses.
    Jönsson KA; Bodemar G; Gotthard R; Norlander B; Walan A
    Eur J Clin Pharmacol; 1983; 24(3):353-6. PubMed ID: 6134622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
    Jansat JM; Costa J; Salvà P; Fernandez FJ; Martinez-Tobed A
    J Clin Pharmacol; 2002 Dec; 42(12):1303-10. PubMed ID: 12463724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration.
    Huupponen R; Paija O; Salonen M; Björklund H; Rouru J; Anttila M
    Drugs R D; 2003; 4(6):339-45. PubMed ID: 14584962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
    Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
    Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of fenoximone, a new cardiotonic, in healthy subjects.
    Alken RG; Belz GG; Haegele KD; Meinicke T; Schechter PJ
    Clin Pharmacol Ther; 1984 Aug; 36(2):209-16. PubMed ID: 6235081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.